Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Facies × 3-ingenyl angelate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 35 Melanosis 3 Warts 2 Keratosis, Seborrheic 1 Keratosis 1 Facies 1 Condylomata Acuminata 1 Carcinoma, Basal Cell 1

Interventions

Sirolimus 1 Interferon-alpha 1 Imiquimod 1 3-ingenyl angelate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01836367 2013-12-31

Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp

Icahn School of Medicine at Mount Sinai

Phase 1 Completed

Facies, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡